Cancer Profiling

 decision foresight.png

Global Cancer Profiling Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2030


The Global Cancer Profiling Market held USD 49576.84 million in 2020, and will register to grow at a CAGR of 18.0% during the forecast period.Cancer is a life-threatening disease, if not treated on time and not using proper treatment. There is uncontrolled and unwanted cell growth caused by environmental reasons that alter the gene encoding responsible for cell regulation. The current available treatments such as radiation and chemotherapy have several side effects including nausea, mild cognitive impairments, and mouth ulcerations. Hence, new and innovative options for the treatment methods are required to reduce the suffering of cancer patients and death. Recently, many researchers and scientists have developed methods such as one-size-fits-all approach for the treatment of cancer. This profiling plays important role in diagnosis along with better understanding of the cancer tumors at the molecular level which is helpful to physicians to make appropriate therapeutic decisions as well as avoid “over-treatment” of the cancer patients. 

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020317

Market Dynamics and Factors:

Rapid geriatric population, growing prevalence of cancer, rise in funding for R&D activities, growing cancer incidences across the globe, accessibility of expenditure for cancer research, and growing usage of biomarkers with low benefit ratio for biomarkers utilized in cancer are the major drivers for the growth of the global cancer profiling market. An efficient and effective result of these profiling methods and favourable government regulations are some of the other positive factors will fuel the growth of market during analysis timeframe.  However, the high cost of treatment and lack of professionals for these methods are responsible to restrain the market growth.  Additionally, the presences of major players in the market coupled with availability of products are also boosting the growth of market during the next coming years. On the contrary, the growing need for point-of-care diagnostic tests and personalized medicine in cancer profiling is creating immense opportunities for the market growth during forecast timeframe. However, on-going global efforts aimed at reducing the cost of treatment and poor regulatory and reimbursement scenario are considered to be the challenge for market in the near future.

Market Segmentation:

  • Global Cancer Profiling Market – By Technology

    • Generation Sequencing (NGS)

    • Polymerase Chain Reaction (PCR),

    • Immunohistochemistry (IHC)

    • In Situ Hybridization (ISH)

    • Microarray

    • Others

  • Global Cancer Profiling Market – By Technique

    • Genomics

    • Proteomics

    • Epigenetics

    • Metabolomics

  • Global Cancer Profiling Market – By Application

    • Personalized Medicine

    • Diagnostics

    • Biomarker Discovery

    • Prognostics

    • Research Applications

  • Global Cancer Profiling Market – By Geography

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • U.K.

      • France

      • Germany

      • Italy

      • Rest of Europe

    • Asia-Pacific

      • Japan

      • China

      • India

      • Australia

      • Rest of Asia Pacific

    • ROW

      • Latin America

      • Middle East

      • Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020317 

Geographic Analysis:

North America was expected to largest share in the growth of the global cancer profiling market, due to the increasing investments for the discovery and development of biomarkers through molecular profiling, rising demand for personalized therapeutics, and rising adoption of advanced omics technologies for cancer research in the region. Europe holds the significant growth rate in the global market attributed to encouraging government plans that are concentrated toward appropriate diagnosing and screening, the existence of large number of technology suppliers, and accessibility of enhanced research & development (R&D) during the forecast time frame.  Furthermore, Asia pacific is anticipated to fastest growing regional market, owing to the rising government initiatives for cancer treatment, prevalence of cancer, and growing healthcare expenditure. As per the Indian Council of Medical Research (ICMR), greater than 1.4 million cancer cases were registered in 2016 and the numbers are further anticipated to reach 1.7 million by 2020 in this region. Latin America and the Middle East & Africa region are projected to moderate growth of the market in these regions during forecast period. In addition, the region is expected to high demand for cost-effective and safe therapeutics and diagnostics during the upcoming years.

Competitive Scenario:

The key players of global cancer profiling markets are Illumina Inc., Abott Molecular, NeoGenomics Laboratories Inc., HTG Molecular Diagnostic, QIAGEN N.V., Boreal Genomics Inc., Caris Life Sciences, Genomic Health Inc., Life Technologies Corporation, and Oxford Gene Technology IP Limited.

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020317 

How will this Market Intelligence Report Benefit You?

  1. The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

  2. Exclusive insight into the key trends affecting the Global Cancer Profiling industry, although key threats, opportunities and disruptive technologies that could shape the Global Cancer Profiling Market supply and demand.

  3. The report tracks the leading market players that will shape and impact the Global Cancer Profiling Market most.

  4. The data analysis present in the Global Cancer Profiling Market report is based on the combination of both primary and secondary resources.

  5. The report helps you to understand the real effects of key market drivers or retainers on Global Cancer Profiling Market business.

The 2021 Annual Global Cancer Profiling Market offers:

  • 100+ charts exploring and analysing the Global Cancer Profiling Market from critical angles including retail forecasts, consumer demand, production and more

  • 15+ profiles of top producing states, with highlights of market conditions and retail trends

  • Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

  • Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Cancer Profiling Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020317 

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: sales@decisionforesight.com

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/


Comments

Popular posts from this blog

Automotive Trailer

High Potency Active Pharmaceutical Ingredients

Capsule Endoscopy